# Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer

> **NCT03426904** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Kyungpook National University Hospital** · enrollment: 708 (estimated)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** Neoadjuvant FOLFOX
- **DRUG:** Conventional adjuvant FOLFOX

## Key facts

- **NCT ID:** NCT03426904
- **Lead sponsor:** Kyungpook National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-10-23
- **Primary completion:** 2028-12-28
- **Final completion:** 2031-12-28
- **Target enrollment:** 708 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03426904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03426904, "Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03426904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*